Delivery Order SPE2DB20D9135-SPE2DB21FD2YX
Award Date
9/9/21
Potential Completion Date
9/30/21
Potential Value
$86K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order worth $10,720.35 under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) valued at up to $499,999,999. The IDC, titled SPE2DB, allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a $5,717.52 firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The contract covers the supply of Nexplanon 68 mg implants, a type of contraceptive, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The contract, valued at $14,293.80, is for the supply of 68 mg NEXPLANON implants, a contraceptive product. The delivery order has a firm fixed-price pricing type and an ultimate completion date of August 22, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The $4,288.14 firm fixed-price delivery order covers the supply of Nexplanon 68 mg implants, a contraceptive product, to support the recurring medical needs of the Department of Defense (DoD) healthcare facilities. The award is part of a larger $499,999,999 single-award indefinite delivery contract (IDC) held by DMS...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) as a delivery order under the SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999. The contract covers a wide range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military healthcare facilities worldwide. The specific delivery...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $8,576.28 under the Defense Logistics Agency's (DLA) SPE2DB program. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive product, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order with a ceiling value of $4,288.14. The contract is for the supply of Nexplanon 68 mg implants, a contraceptive product, to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of Nexplanon 68 mg contraceptive implants to the Defense Logistics Agency's (DLA) Medical Supply Chain division. The $5,717.52 firm fixed-price delivery order falls under a larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to issue orders for a comprehensive range of pharmaceutical products to support the medical supply needs of Department...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the DLA's SPE2DB program. The $8,576.28 award is for the supply of Nexplanon 68 mg implants, a contraceptive product. DMS Pharmaceutical Group has a significant $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) to provide a comprehensive range of pharmaceutical items, including common medications and specialized drugs, to...
This is a $10,720.35 firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB contract vehicle. The contract is for the delivery of 4564598924 units of the Nexplanon 68 mg contraceptive implant. This single-award indefinite delivery contract, valued up to $499,999,999, allows the DLA to issue delivery orders for a wide range of pharmaceutical items to support the...